Biobase Blood Coagulation Analyzer Semi Automatic Coagulation Analyzer

Name: Biobase Blood Coagulation Analyzer Semi Automatic Coagulation Analyzer
Brand: Biobase Biodustry (Shandong) Co., Ltd.
SKU: 1940481911

Shandong, ChinaBiobase Biodustry (Shandong) Co., Ltd.

US$299.00-529.00

1 Piece

Sample price:US$525.00/piece.Request sample

Product profile

Customization

Available

Classification

Imaging Diagnostic Equipment

Type

Blood Coagulation Analyzer

Model NO.

BK-CA02

Certification

CE, FDA, MSDS, ISO13485

Group

All

Model

Bk-Ca02

Test Principle

Optical Colorimetry

Test Items

PT, Aptt, Tt, Fib

Test Channel

Wavelength

470nm

Detection Time

Normal Sample Detection Time Is 20 to 40 Seconds,

Sample Incubation Position

Reagent Incubation Position

Detection Position Temperature

37.0±1.0°C

Incubation Position Temperature

37.0±1.0°C

Incubation Time

1-999s

Reaction Time

1-99s

Reagent Dosage Minimum Dosage

20μL

Sample Volume

20μL~40μL

Display

5-Inch High-Definition Color Touch Screen

Transport Package

Standard Export Packaging

Specification

376*246*316mm

Trademark

BIOBASE

Origin

China

Production Capacity

50000/Year

Company profile

Importers and ExportersYears of Export ExperienceExperienced TeamExhibition Experience

Biobase Biodustry (Shandong) Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 15 years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤3.73h

AI-Powered supplier vetting

SummaryThe supplier is identified as a combined company involved in medical-device sales, manufacturing, research and development, and related technical activities. It reports ISO9001:2015, ISO14001, and CE certifications, 100% finished-product inspection, five quality inspectors, and stated annual production capacities for Biological Safety Cabinets and Auto Chemistry Analyzers. R&D evidence includes new products in the past year, ODM services, and broad customization from samples, designs, or full specifications. Overseas support includes installation, repair, training, maintenance, and debugging, with overseas warehouses and agents or branches. Financial records are identified for 2022–2024, but no financial performance values are provided. Evidence of customer cases is limited to OEM service for popular brands and participation in the Pittcon Exhibition.

Supplier typeThe supplier is classified as a combined company. Its stated scope covers Class I, II, and III medical-device activities, including sales, production, research and development, medical services, and related installation or construction activities.

CertificationsThe supplier reports ISO9001:2015 and ISO14001 certifications, as well as CE product certification capability. The slices do not provide certificate validity dates or scope details, but they explicitly identify multiple certifications.

After-Sales capabilityThe supplier lists overseas installation, repair, training, maintenance, and debugging services, and reports overseas warehouses plus overseas agents or branches. It also has written service-capability procedures with follow-up records and 20 qualified service suppliers, although the stated overseas-service country count is zero.

R&D capabilityThe supplier reports new products during the past year, provides ODM services, and offers broad R&D customization. It does not have an available SDK, which limits evidence of software-development support but does not negate the documented product-development capability.

Production capacityThe supplier reports annual capacities of 10,000 Biological Safety Cabinets and 11,100 Auto Chemistry Analyzers, with laser cutting equipment and a bending machine. Its stated business scope also includes production of Class I, II, and III medical devices, while the adequacy of equipment and capacity for a specific order is not established.

Customization capabilityBoth R&D and design-capability records list customization from samples, customization from designs, full customization, minor customization, and flexible customization. This is explicit evidence of a broad customization offering.